Published Date: 04 Mar 2023
Karnataka: Karnataka Examination Authority (KEA) yog PG AYUSH ...
Read Full NewsAI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!
Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.
1.
Study: Discovery of cellular identity may influence cancer treatment
2.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
3.
The Truth About Apple AirPods
4.
Which Risk Model Better Identifies High-Risk Smoldering MM?
5.
No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy
1.
The Growing Crisis of Aplastic Anemia: A Call for Action
2.
Prognostic Patterns of Functional Recovery During Long-Term Cancer Survivorship
3.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
4.
Quality of Life Through Maintaining Functional Independence During Chronic Hematologic Conditions
5.
Pathophysiology of Platelet Production Failure
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Signs and Symptoms of Leukemia
4.
Diagnosis and Management in Hematology
5.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation